10x Genomics Income from Continuous Operations 2018-2025 | TXG

10x Genomics income from continuous operations from 2018 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
10x Genomics Annual Income from Continuous Operations
(Millions of US $)
2024 $-183
2023 $-255
2022 $-166
2021 $-58
2020 $-543
2019 $-31
2018 $-112
2017 $-19
10x Genomics Quarterly Income from Continuous Operations
(Millions of US $)
2025-03-31 $-34
2024-12-31 $-49
2024-09-30 $-36
2024-06-30 $-38
2024-03-31 $-60
2023-12-31 $-49
2023-09-30 $-93
2023-06-30 $-62
2023-03-31 $-51
2022-12-31 $-17
2022-09-30 $-42
2022-06-30 $-64
2022-03-31 $-42
2021-12-31 $-18
2021-09-30 $-17
2021-06-30 $-11
2021-03-31 $-12
2020-12-31 $-416
2020-09-30 $-66
2020-06-30 $-40
2020-03-31 $-21
2019-12-31 $-7
2019-09-30 $-10
2019-06-30 $-11
2019-03-31 $-4
2018-12-31
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.691B $0.611B
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.594B 60.55
Hims & Hers Health (HIMS) United States $12.830B 133.30
Doximity (DOCS) United States $11.392B 52.74
Tempus AI (TEM) United States $10.965B 0.00
IRhythm Technologies (IRTC) United States $4.223B 0.00
Inspire Medical Systems (INSP) United States $3.794B 59.28
Hinge Health (HNGE) United States $3.587B 0.00
Privia Health (PRVA) United States $2.402B 164.17
Schrodinger (SDGR) United States $1.650B 0.00
Phreesia (PHR) United States $1.610B 0.00
Clover Health Investments (CLOV) United States $1.565B 0.00
Azenta (AZTA) United States $1.555B 72.25
Enovis (ENOV) United States $1.551B 8.65
Omnicell (OMCL) United States $1.318B 23.25
Evolent Health (EVH) United States $1.098B 93.50
Claritev (CTEV) United States $0.686B 0.00
Fulgent Genetics (FLGT) United States $0.560B 0.00
Standard BioTools (LAB) United States $0.558B 0.00
Veradigm (MDRX) United States $0.523B 0.00
Butterfly Network (BFLY) United States $0.514B 0.00
Talkspace (TALK) United States $0.422B 126.00
TruBridge (TBRG) United States $0.349B 775.00
Outset Medical (OM) United States $0.312B 0.00
Health Catalyst (HCAT) United States $0.268B 0.00
Nyxoah SA (NYXH) Belgium $0.265B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.241B 0.00
CapsoVision (CV) United States $0.198B 0.00
Zepp Health (ZEPP) Netherlands $0.165B 0.00
KORU Medical Systems (KRMD) United States $0.162B 0.00
American Well (AMWL) United States $0.136B 0.00
Pulmonx (LUNG) United States $0.133B 0.00
EUDA Health Holdings (EUDA) Singapore $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.115B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.106B 0.00
CareCloud (CCLD) United States $0.100B 3.82
Insight Molecular Diagnostics (IMDX) United States $0.085B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.027B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Healthcare Triangle (HCTI) United States $0.022B 0.00
Precipio (PRPO) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00